← Evidence map

ArticleJCI insight2018

CD226 opposes TIGIT to disrupt Tregs in melanoma.

Julien Fourcade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

130 papers cite itlatest 60 shown

2018
…
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30046006